Market revenue in 2023 | USD 83.6 million |
Market revenue in 2030 | USD 227.1 million |
Growth rate | 15.4% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.74% in 2023. Horizon Databook has segmented the Asia Pacific mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to witness the fastest growth in the miRNA sequencing & assay market during the forecast period. Various organizations and associations are taking initiatives to create and educate young scientists in this region.
For instance, APBioNet is an Asia Pacific bioinformatics network that is intended to track development of bioinformatics infrastructure and exchange of data & information and provide training programs, workshops, & conferences.
This network also encourages collaborations in the field of bioinformatics. The presence of such organizations in the region is expected to impel miRNA sequencing & assay market growth. In addition, presence of significant target population, developing healthcare infrastructure, and presence of high unmet clinical needs are anticipated to provide growth opportunities to key manufacturers in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific mirna sequencing and assay market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account